Helicobacter Pylori and Chronic Dyspepsia in Eastern Uganda

Phase 1, open-label trial of clarithromycin, amoxicillin and omeprazole in Helicobacter pylori infection and dyspepsia (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Eradication of Helicobacter pylori among Helicobacter pylori positive participants and Number of total participants at the beginning of the study who are positive for Helicobacter pylori at 7 months. Started Oct 2018; status: completed.